Geneos Wealth Management Inc. Vertex Pharmaceuticals Inc Transaction History

Geneos Wealth Management Inc.

$2.6 Billion
Q3 2024

A detailed history of Geneos Wealth Management Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 1,697 shares of VRTX stock, worth $765,296. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,697

Previous 74 2193.24%

Holding current value

$765,296

Previous $34,000 2220.59%

% of portfolio

0.03%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $746,580 - $820,880	1,623 Added 2193.24%	1,697 $789,000
Q2 2024 Jul 23, 2024	BUY	$392.81 - $485.53 $1,964 - $2,427	5 Added 7.25%	74 $34,000
Q1 2024 May 03, 2024	SELL	$407.69 - $446.08 $6,115 - $6,691	-15 Reduced 17.86%	69 $28,000
Q4 2023 Jan 26, 2024	SELL	$343.0 - $410.68 $36,701 - $43,942	-107 Reduced 56.02%	84 $34,000
Q3 2023 Oct 11, 2023	BUY	$338.18 - $362.46 $18,261 - $19,572	54 Added 39.42%	191 $66,000
Q2 2023 Aug 08, 2023	BUY	$314.42 - $351.91 $40,874 - $45,748	130 Added 1857.14%	137 $48,000
Q1 2023 Apr 25, 2023	SELL	$283.23 - $323.1 $33,987 - $38,772	-120 Reduced 94.49%	7 $2,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $87,077 - $97,158	-318 Reduced 71.46%	127 $36,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $26,570 - $31,316	120 Added 36.92%	445 $116,000
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $17,701 - $22,345	100 Added 44.44%	325 $71,000
Q3 2021 Nov 09, 2021	BUY	$181.39 - $202.99 $181 - $202	1 Added 0.45%	225 $40,000
Q2 2021 Jul 08, 2021	SELL	$187.49 - $221.1 $446,226 - $526,218	-2,380 Reduced 91.4%	224 $44,000
Q1 2021 Jun 17, 2021	SELL	$207.02 - $241.31 $73,285 - $85,423	-354 Reduced 11.97%	2,604 $568,000
Q4 2020 May 19, 2021	BUY	$207.01 - $276.09 $486,473 - $648,811	2,350 Added 386.51%	2,958 $605,000
Q3 2020 Sep 07, 2021	SELL	$255.65 - $303.1 $76,695 - $90,930	-300 Reduced 33.04%	608 $163,000
Q2 2020 Sep 07, 2021	BUY	$225.48 - $295.8 $60,879 - $79,866	270 Added 42.32%	908 $259,000
Q1 2020 Sep 07, 2021	BUY	$199.77 - $247.81 $19,977 - $24,781	100 Added 18.59%	638 $138,000
Q3 2019 Sep 07, 2021	BUY	$166.23 - $187.09 $2,327 - $2,619	14 Added 2.67%	538 $89,000
Q2 2019 Sep 07, 2021	SELL	$164.61 - $190.37 $8,230 - $9,518	-50 Reduced 8.71%	524 $96,000
Q1 2019 Sep 07, 2021	SELL	$163.73 - $194.7 $3,929 - $4,672	-24 Reduced 4.01%	574 $105,000
Q3 2018 Sep 07, 2021	BUY	$167.73 - $192.74 $4,864 - $5,589	29 Added 5.1%	598 $115,000
Q2 2018 Sep 07, 2021	SELL	$145.72 - $169.96 $10,200 - $11,897	-70 Reduced 10.95%	569 $96,000
Q4 2017 Sep 07, 2021	SELL	$137.28 - $155.55 $9,197 - $10,421	-67 Reduced 9.49%	639 $95,000
Q3 2017 Sep 07, 2021	BUY	$148.13 - $162.24 $67,102 - $73,494	453 Added 179.05%	706 $107,000
Q1 2017 Sep 07, 2021	SELL	N/A	-22 Reduced 8.0%	253 $27,000
Q3 2016 Sep 07, 2021	BUY	N/A	22 Added 8.7%	275 $23,000
Q1 2016 Sep 07, 2021	BUY	N/A	253	253 $20,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.

Account

Geneos Wealth Management Inc. Vertex Pharmaceuticals Inc Transaction History